(Q51918808)

17 April 2018

title

Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders. (English)

1 reference

17 April 2018

1 reference

Mijch A

1

1 reference

17 April 2018

Burgess P

2

1 reference

17 April 2018

Judd F

3

1 reference

17 April 2018

Grech P

4

1 reference

17 April 2018

Komiti A

5

1 reference

17 April 2018

Hoy J

6

1 reference

17 April 2018

Lloyd JH

7

1 reference

17 April 2018

Gibbie T

8

1 reference

17 April 2018

Street A

9

1 reference

17 April 2018

publication date

1 May 2006

1 reference

17 April 2018

published in

HIV Medicine

1 reference

17 April 2018

volume

7

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

205-212

1 reference

17 April 2018

HIV seroprevalence among people with severe mental illness in the United States: a critical review

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Psychopathology in human immunodeficiency virus infection: lifetime and current assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

DSM-IV mental disorders and neurological complications in children and adolescents with human immunodeficiency virus type 1 infection (HIV-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Combination antiretroviral therapy and improvements in mental health: results from a nationally representative sample of persons undergoing care for HIV in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Manic syndrome associated with efavirenz overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Management of psychiatric disorders in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Social indicators and the prediction of psychiatric inpatient service utilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Long-term Course of Hospitalization for Schizophrenia: Part I. Risk for Rehospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Meta-analysis of the relationship between HIV infection and risk for depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00359.X

10.1111/J.1468-1293.2006.00359.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018